Enlight Medical

Enlight Medical Limited, based in Shanghai, is dedicated to the product development, manufacturing, and sales of innovative medical devices. The company's operations span fields such as structural heart disease, peripheral vascular intervention, neurostimulation, and brain-computer interface platforms. Currently, four Class III medical device products, including the Thoracic Aortic Stent Graft System, have obtained NMPA registration certificates, while several other products, such as the Mitral Valve Repair System, are in the research and development and clinical stages. The founding team has extensive experience and industry resources in R&D, entrepreneurship, management, and finance. The R&D team consists of senior engineers who graduated from renowned universities both domestically and internationally, such as Harvard University, MIT, Fudan University, Shanghai Jiao Tong University, and the University of Chinese Academy of Sciences. With a research base in the United States, key members possess over 15 years of R&D experience. The company’s product pipeline is broad, covering multiple innovative products for treating structural heart disease and pan-vascular conditions, with significant market potential. With an international perspective, Enlight Medical will always adhere to the principle of compassion, establish itself in China, and strive to become a world-class provider of advanced technology and a manufacturer of innovative medical devices.